Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VEGF 165 (Active) Protein

Origin: Human Host: Escherichia coli (E. coli) Recombinant >95 % (SDS-PAGE) SDS Active
Catalog No. ABIN2746010
  • Target
    VEGF 165
    Protein Type
    Recombinant
    Biological Activity
    Active
    Origin
    • 17
    • 3
    • 2
    Human
    Source
    • 10
    • 7
    • 1
    • 1
    • 1
    • 1
    • 1
    Escherichia coli (E. coli)
    Application
    SDS-PAGE (SDS)
    Cross-Reactivity
    Human
    Characteristics
    Human VEGF 165 (165aa).
    Purity
    >95 % (SDS-PAGE)
    Endotoxin Level
    <0.1ng/μg protein.
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    The ED50 for stimulation of cell proliferation in human umbilical vein endothelial cells by VEGF 165 has been determined to be in the range of 1-5ng/ml.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstitute with 50 mM acetic acid to a concentration not lower than 50 μg/mL.
    Concentration
    Lot specific
    Buffer
    Lyophilized.
    Storage
    4 °C,-20 °C
    Storage Comment
    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 6 months after receipt when stored at -20°C.
    Expiry Date
    6 months
  • Target
    VEGF 165
    Background
    Human vascular endothelial growth factor (VEGF 165) is produced as a homodimer. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. VEGF 165 is a specific mitogen for vascular endothelial cells and a strong angiogenic factor in vivo. In addition to its action as a mitogen it is a potent vascular permeability factor (VPF) in vivo. It is also a chemoattractant molecule for monocytes and endothelial cells. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
    Molecular Weight
    ~38.2kDa
You are here:
Support